Smart Labels Market for Healthcare and Pharmaceutical Industry Size, Share, & Industry Analysis Report By Product (Passive RFID Labels, Active RFID Labels), By End Use, and By Region – Market Forecast, 2025–2034

The smart labels market in the healthcare and pharmaceutical industry size is expected to reach USD 12.39 Billion by 2034, according to a new study by Polaris Market Research. The report “Smart Labels Market for Healthcare and Pharmaceutical Industry Size, Share, Trends, & Industry Analysis Report By Product (Passive RFID Labels, Active RFID Labels), By End Use, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The smart labels market in the healthcare and pharmaceutical industry is growing steadily due to the rising need for accurate tracking, secure packaging, and real-time data monitoring. Technologies such as radio-frequency identification (RFID), NFC, QR codes, and embedded sensors are integrated into pharmaceutical labeling to improve safety, efficiency, and compliance.

Increased focus on supply chain visibility and regulatory mandates is pushing broader adoption of smart labeling across drug packaging, medical devices, and clinical trial logistics. Integration of smart labels into digital systems is helping companies streamline inventory management and ensure timely product delivery.

Smart Labels Market for Healthcare and Pharmaceutical Industry Report Highlights

Based on product type, the passive RFID segment dominated the market in 2024, driven by growing adoption in pharmaceutical inventory tracking and automated drug identification across distribution and retail channels.

In terms of end use, the prescription drug packaging segment dominated the market in 2024. This is driven by rising requirements for drug serialization, traceability, and anti-counterfeiting measures under regulations such as the US Drug Supply Chain Security Act and the EU Falsified Medicines Directive.

Asia Pacific accounted for the majority share of the global smart labels market for healthcare and pharmaceutical industry in 2024, attributed to stricter regulatory oversight and reforms focused on ensuring drug authenticity and supply chain visibility.

North America held significant market share during the forecast period, owing to established regulatory systems prioritizing serialization compliance, secure packaging, and digital data accuracy.

A few global key market players include CCL Industries Inc., Datalogic S.p.A., ID Tech Solutions Private Limited, Intellhydro Technology Pvt. Ltd., Invengo Information Technology Co., Ltd., RFiD Discovery (a brand of Paragon ID), SATO Asia Pacific Pte. Ltd., Schreiner Group GmbH & Co. KG, Tadbik Ltd., Avery Dennison Corporation, Honeywell International Inc., Zebra Technologies Corporation, William Frick & Company, Brady Corporation, and Thin Film Electronics ASA.

Polaris Market Research has segmented the market report on the basis of product type, end use, and region:

By Product Type Outlook (Revenue, USD Billion, 2020–2034)

Passive RFID Labels

Active RFID Labels

NFC Labels

QR Code & 2D Barcode Labels

Sensor-Embedded Smart Labels

By End Use Outlook (Revenue, USD Billion, 2020–2034)

Prescription Drug Packaging

Vaccine & Biologics Shipment

Medical Devices & Instrumentation

Hospital Asset Management

Clinical Trial Logistics

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America Show more